Medfinder
Back to blog

Updated: January 19, 2026

Altreno Availability: What Providers and Prescribers Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Healthcare provider reviewing medication supply data at desk with stethoscope

Altreno (tretinoin lotion 0.05%) is not in a formal FDA shortage, but your patients are struggling to fill it. Here's what prescribers need to know and do in 2026.

Altreno (tretinoin lotion 0.05%) isn't in a formal drug shortage, but if you prescribe it — or are considering prescribing it — you should be aware that your patients are frequently unable to fill it at their local pharmacy. This guide covers the clinical and logistical realities of Altreno availability in 2026, along with practical strategies to reduce prescribing friction for your patients.

Clinical Overview: What Is Altreno and Why Might You Prescribe It?

Altreno (tretinoin 0.05% lotion) is FDA-approved for acne vulgaris in patients 9 years of age and older. Its primary clinical differentiator is its lotion vehicle — formulated with hyaluronic acid, glycerin, and soluble collagen. This delivery system reduces the drying and irritation typically associated with tretinoin, making it a strong option for:

Patients with dry, combination, or sensitive skin who have previously discontinued tretinoin due to irritation

Pediatric patients (ages 9+) where tolerability is especially important for long-term adherence

Patients who have expressed frustration with the drying effects of standard tretinoin cream or gel

Adults who desire tretinoin's additional anti-aging benefits alongside acne treatment, in a more skin-friendly formulation

Clinical trial data shows that less than 4% of patients reported significant dryness in Phase 3 trials — a meaningful improvement over traditional tretinoin formulations. Two randomized, double-blind, vehicle-controlled Phase 3 trials confirmed efficacy in patients 9 years of age and older after 12 weeks of once-daily application.

Why Patients Are Struggling to Fill Altreno Prescriptions

There are three primary reasons your patients may return to you or contact your office reporting they cannot fill their Altreno prescription:

Pharmacy stocking gaps. Altreno is brand-name only with no generic. Its relatively low prescription volume means many pharmacies — including large chains — don't routinely carry it or allow stock to lapse between orders. This is not a manufacturing shortage; the drug is available in the distribution chain.

Formulary barriers. Many commercial insurance plans (including UnitedHealthcare) either exclude brand-name topical retinoids entirely or require prior authorization with step therapy documentation showing that generic tretinoin was tried first. This creates delays in coverage approval and sometimes results in patients going without their medication for weeks.

Cost without coverage. Retail cash prices for Altreno can reach $200–$400 per 45g tube. Without insurance coverage or the manufacturer copay card, many patients can't afford it even if it's in stock.

Prescribing Strategies to Improve Access for Your Patients

The following workflow modifications can reduce the number of patients who contact your office unable to fill their Altreno prescription:

Check insurance formulary before prescribing. Use your EHR's formulary check tool or contact the pharmacy benefit manager before writing the prescription. If Altreno is not covered or requires PA, initiate the PA at the time of prescribing rather than after the patient hits a roadblock.

Indicate the medical necessity in the prescription. If your patient has documented skin sensitivity or a prior adverse reaction to generic tretinoin, include this in the prior authorization documentation. This strengthens the PA and may reduce back-and-forth.

Refer patients to the manufacturer copay card. Ortho Dermatologics (Bausch Health) offers a copay assistance card that can reduce out-of-pocket costs to as low as $0 for eligible commercially insured patients. This does not apply to Medicare or Medicaid. Direct your staff to include the copay card information in the after-visit summary.

Direct patients to medfinder. medfinder for Providers is a tool that helps identify which pharmacies near a patient have a medication in stock — saving your staff time fielding calls from patients who can't fill. Share medfinder.com/providers with your office manager or MA for workflow integration.

Build in a backup prescription. When prescribing Altreno, consider also providing a prescription for generic tretinoin cream 0.05% or adapalene 0.3% gel as a "use if Altreno is unavailable" backup. This reduces patient dropout from therapy if the first prescription can't be filled.

Important Prescribing Notes for Altreno

Fish allergy: Altreno contains soluble fish proteins and collagen. Counsel patients with known fish allergies to watch for pruritus or urticaria and to contact your office if these develop.

Pregnancy: Tretinoin is a known teratogen in oral form. While systemic absorption from topical Altreno is low, the prescribing information advises caution in pregnancy. Counsel patients of reproductive potential accordingly.

Sun sensitivity: Advise patients to minimize UV exposure and use SPF 30+ sunscreen daily while on Altreno.

Resources for Your Practice

medfinder for Providers — find which pharmacies near your patients have Altreno in stock

How to Help Your Patients Find Altreno in Stock: A Provider's Guide

Ortho Dermatologics / Bausch Health for copay card enrollment details: 1-800-321-4576

Frequently Asked Questions

No. As of 2026, Altreno is not listed on the FDA drug shortage database. Bausch Health continues to manufacture it. The access challenge is a pharmacy stocking and formulary coverage issue, not a manufacturing shortage.

Coverage varies significantly. Many commercial plans require prior authorization and step therapy (documenting that generic tretinoin was tried first) before approving Altreno. Some plans (e.g., UnitedHealthcare) explicitly exclude brand-name topical retinoids. Always check formulary status at the time of prescribing.

Altreno contains soluble fish proteins and collagen. Advise patients with known fish allergies to use with caution and report any pruritus or urticaria immediately. This is a unique consideration that distinguishes Altreno from all other tretinoin formulations.

Generic tretinoin cream 0.05% is the most direct substitute with the same active ingredient. Adapalene 0.3% gel (Rx) or 0.1% gel (OTC) is a gentler option with similar efficacy. Arazlo (tazarotene 0.045% lotion) is a more potent option if tolerability is less of a concern.

medfinder contacts pharmacies near your patient's location to identify which ones have Altreno in stock, then texts results to the patient. This reduces callbacks to your office from patients who can't fill. Providers can share medfinder.com/providers with their practice staff.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Altreno also looked for:

36,837 have already found their meds with Medfinder.

Start your search today.

36K+
5-star ratingTrusted by 36,837 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?